Estimaciones de analistas de Wall Street para Nautilus Biotechnolgy, Inc. (NAUT): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-10-27 | $-0.14 | ||
| 2026-07-28 | $-0.11 | $-0.14 | +18.5% |
| 2026-04-28 | $-0.12 | $-0.14 | +17.2% |
| 2026-02-26 | $-0.11 | $-0.14 | +21.4% |
| 2025-10-27 | $-0.11 | $-0.15 | +26.7% |
| 2025-07-31 | $-0.12 | $-0.15 | +22.6% |
| 2025-04-29 | $-0.13 | $-0.14 | +7.1% |
| 2025-02-26 | $-0.14 | $-0.16 | +12.5% |
Ratios de valoración
| Precio / Valor contable | 1.06 |
| EV / EBITDA | -2.63 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | $2.3M | $2.8M | 0 | $5.7M | $6.4M | $6.5M |
| Beneficio Bruto | 0 | 0 | -$2.3M | -$2.8M | 0 | -$5.7M | -$6.4M | -$6.5M |
| I+D | 0 | $8.5M | $10.1M | $26.5M | $37.7M | $47.3M | $50.5M | $41.1M |
| Generales y Administrativos | $111.7M | $1.6M | $3.3M | $21.1M | $25.9M | $28.9M | $31.0M | $25.7M |
| Gastos Operativos | $111.7M | $10.1M | $13.4M | $47.7M | $63.6M | $70.4M | $75.1M | $60.4M |
| Beneficio Operativo | -$111.7M | -$10.1M | -$15.7M | -$50.5M | -$63.6M | -$76.2M | -$81.5M | -$66.8M |
| EBITDA | $626.6M | -$9.6M | -$13.3M | -$47.5M | -$60.1M | -$61.8M | -$64.4M | -$52.5M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | $626.6M | -$9.6M | -$15.6M | -$50.3M | -$57.9M | -$63.7M | -$70.8M | -$59.0M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | $626.6M | -$9.6M | -$15.6M | -$50.3M | -$57.9M | -$63.7M | -$70.8M | -$59.0M |
| BPA | $87.18 | $-1.59 | $-0.47 | $-0.60 | $-0.46 | $-0.51 | $-0.56 | $-0.47 |
| BPA Diluido | $87.18 | $-1.59 | $-0.47 | $-0.60 | $-0.46 | $-0.51 | $-0.56 | $-0.47 |
| Acciones en Circulación (Diluidas) | $7.2M | $6.1M | $33.1M | $84.5M | $124.6M | $124.9M | $125.4M | $126.3M |
Precio
| Precio | $0.97 |
| Capitalización | $124M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ARCT · ASMB · ENTA · FHTX · HUMA · IMRX · PYXS
Explorar sector: Healthcare · Biotechnology
Más secciones de NAUT: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones